Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down (Q33268159)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down |
scientific article |
Statements
1 reference
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down (English)
1 reference
Gillian M Tozer
1 reference
Katharine J Lankester
1 reference
Ross J Maxwell
1 reference
R Barbara Pedley
1 reference
Jason L Dearling
1 reference
Uzma A Qureshi
1 reference
Ethaar El-Emir
1 reference
Sally A Hill
1 reference
1 February 2007
1 reference
1 reference
30
1 reference
453-460
1 reference
Identifiers
1 reference